You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RGNX Sale Disclosure
Pakola Steve · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$472.28K
Pakola Steve Chief Medical Officer
RGNX
REGENXBIO Inc
RGNX
Transaction date
Jul 1, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed same day
RGNX daily price context
Close on/before transaction
$13.09
Jul 1, 2026
First close after public filing
$13.28
Jul 2, 2026
30-day return after filing
-27.03%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 36,725 shares @ $12.86
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001700659-26-000012
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$977.41K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regenxbio Inc. RGNX | Exercise | Jul 1, 2026 | $0 |
| Regenxbio Inc. RGNX | Exercise | Jul 1, 2026 | $288.66K |
| Regenxbio Inc. RGNX Current | Sale | Jul 1, 2026 | $472.28K |
| Regenxbio Inc. RGNX | Sale | Jun 29, 2026 | $216.47K |